ARCH Venture Partners VII, LLC's Net Worth

$672 Million

Who is ARCH Venture Partners VII, LLC?

ARCH Venture Partners VII, LLC has an estimated net worth of $672 Million. This is based on reported shares across multiple companies, which include PHASERX, INC., AGIOS PHARMACEUTICALS INC, Neumora Therapeutics, Inc., Receptos, Inc., 908 Devices Inc., Pulmatrix, Inc., bluebird bio, Inc., Twist Bioscience Corp, Sage Therapeutics, Inc., Unity Biotechnology, Inc., Syros Pharmaceuticals, Inc., and Juno Therapeutics, Inc..

SEC CIK

ARCH Venture Partners VII, LLC's CIK is 0001544443

Past Insider Trading and Trends

2018 was ARCH Venture Partners VII, LLC's most active year for acquiring shares with 15 total transactions. ARCH Venture Partners VII, LLC's most active month to acquire stocks was the month of April. 2014 was ARCH Venture Partners VII, LLC's most active year for disposing of shares, totalling 13 transactions. ARCH Venture Partners VII, LLC's most active month to dispose stocks was the month of April. 2023 saw ARCH Venture Partners VII, LLC paying a total of $25,500,000.00 for 18,924,704 shares, this is the most they've acquired in one year. In 2014 ARCH Venture Partners VII, LLC cashed out on 24,272,413 shares for a total of $1,345,906.01, their largest year based on trade value.